← Back
Data updated: Mar 10, 2026
STIEFEL
Dermatology
STIEFEL is a pharmaceutical company focused on Dermatology.
1996
Since
4
Drugs
-
Trials
14
Approved (2yr)
Key Drugs
No active drugs
Recent Activity
HYDROCORTISONE 2025-05-02
HYDROCORTISONE 2025-02-03
Labeling
HYDROCORTISONE 2025-02-03
Labeling
HYDROCORTISONE 2024-11-26
Labeling
HYDROCORTISONE 2024-11-26
Labeling
HYDROCORTISONE 2024-11-25
HYDROCORTISONE 2024-09-25
Labeling
HYDROCORTISONE 2024-09-25
Labeling
HYDROCORTISONE 2024-09-05
Labeling
HYDROCORTISONE 2024-06-11
Labeling
SEC Filings
Pro
Loading...
Therapeutic Focus
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Dermatology 100%
1 drugs Phase 1: 1
Pipeline Strength Pro
Loading...
Active (1)
Discontinued (3)
Company Info
- First Approval
- 1996-10-28
- Latest
- 2023-02-22
- Applications
- 5
FDA Sponsor Names
STIEFELSTIEFEL LABS INC